Quest Diagnostics (DGX) free cash flow

Free cash flow · fiscal 2025
$1.36B

Quest Diagnostics (DGX) generated free cash flow of $1.36B in fiscal 2025 (the year ended December 31, 2025). That is 49.5% higher than the $909.00M of fiscal 2024. Figures as of 18 Nov 2026, 12:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$1.36B
Change on fiscal 2024
+49.5%
Growth, 5 years
−3.1% a year
Growth, 10 years
+9.3% a year
Highest on record
$1.83Bfiscal 2021
Lowest on record
$421.00Mfiscal 2013
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Quest Diagnostics free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow shrank at a compound 3.1% a year; over ten years the rate was 9.3% a year. Across the 19 fiscal years on record (2007–2025), the highest was $1.83B in fiscal 2021 and the lowest $421.00M in fiscal 2013.

History · 19 fiscal years

Free cash flow by fiscal year

Quest Diagnostics free cash flow, year by year

Quest Diagnostics (DGX) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$1.36B 49.5% up
2024$909.00M 5.2% up
2023$864.00M 34.2% down
2022$1.31B 28.2% down
2021$1.83B 15.3% up
2020$1.59B 88.3% up
2019$843.00M 3.2% up
2018$817.00M 11.5% down
2017$923.00M 12.2% up
2016$823.00M 47.5% up
2015$558.00M 12.3% down
2014$636.00M 51.1% up
2013$421.00M 58.1% down
2012$1.01B 36.9% up
2011$734.00M 19.6% down
2010$912.65M 9.9% up
2009$830.49M 2.3% down
2008$850.37M 20.1% up
2007$707.82M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Quest Diagnostics and comparable companies
CompanyFree cash flowFiscal year
DexCom DXCM$1.08B2025
Koninklijke Philips PHG€504.00M2025
Quest Diagnostics DGX$1.36B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DGX

Quest Diagnostics, figure by figure

Quest Diagnostics (DGX) overview: price, valuation and scorecardAll health care companies by market value

Quest Diagnostics free cash flow: questions and answers

What is Quest Diagnostics's free cash flow?

Quest Diagnostics (DGX) generated free cash flow of $1.36B in fiscal 2025 (the year ended December 31, 2025). That is 49.5% higher than the $909.00M of fiscal 2024.

What is the growth rate of Quest Diagnostics's free cash flow?

Over the five fiscal years to 2025 free cash flow shrank at a compound 3.1% a year; over ten years the rate was 9.3% a year.

What are the highest and lowest free cash flow figures on record for Quest Diagnostics?

Across the 19 fiscal years on record (2007–2025), the highest was $1.83B in fiscal 2021 and the lowest $421.00M in fiscal 2013.

How is Quest Diagnostics's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Quest Diagnostics it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Quest Diagnostics (DGX) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/DGX/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.